Delivery Order SPE2DB22D3501-SPE2DB25FTU04

Award Date 12/11/24
Potential Completion Date 12/12/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTU04
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml. The award, valued at $2,634.84, is a Firm Fixed Price Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC has a ceiling value of $999,999,999 and runs through November 2026, allowing for the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp plays a critical role in supplying medical products to federal government agencies, including the DLA, the Department of Justice Federal Bureau of Investigation, and other military and veterans' healthcare systems.

Generated 3/12/25, 10:01 AM